Skip to main content
TipRanks
Go Ultimate75% OFF

Qianhai Health Holdings Ltd. (0911) Stock Price & Analysis

0 Followers

0911 Stock Chart & Stats

HK$0.32-HK$0.01(-1.56%)
At close: 4:00 PM GMT+8
HK$0.3HK$0.4HK$0.5HK$0.6Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
HKD 0.30 - HKD 0.32
52-Week Range
HKD 0.24 - HKD 1.40
Previous Close
HKD 0.32
Volume
N/A
Average Volume (3M)
45.06K
Market Cap
HKD 54.22M
Enterprise Value
HKD 90.67M
Total Cash (Recent Filing)
HKD 17.88M
Total Debt (Recent Filing)
HKD 107.00K
Price to Earnings (P/E)
13.3
Beta
0.10
Next Earnings
Apr 01, 2027 (Est.)
EPS Estimate
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Very Low Leverage

The extremely conservative financing structure limits interest and refinancing pressure while preserving financial flexibility. A large equity base gives the company greater capacity to withstand operating volatility, support working capital, and fund future initiatives without materially increasing leverage.

Improved Cash Generation

The sharp improvement in operating and free cash flow indicates that recent profitable operations are translating into internally generated funds. This strengthens liquidity, reduces reliance on external financing, and provides a more durable base for maintaining operations and pursuing growth.

Financial Turnaround

The return to positive earnings and operating profit marks a meaningful recovery from the large losses of 2022–2023. The 2025 revenue rebound also suggests renewed business activity, improving the company’s ability to sustain operations and rebuild earnings power over coming periods.

Bears Say

Very Thin Profitability

Extremely narrow margins leave little room to absorb pricing pressure, cost increases, or weaker demand. The decline from 2024 indicates that the earnings recovery remains fragile, so even modest operating deterioration could materially reduce profit and cash generation.

Volatile Earnings History

The recent recovery follows a materially unstable financial history rather than a long record of consistent profitability. Prior losses and cash burn increase uncertainty around earnings durability and suggest that future results may remain sensitive to changes in operating performance.

Low Capital Efficiency

Positive ROE is an improvement, but a level near 1.5% indicates that the substantial equity base is generating limited returns. Persistently low capital efficiency can constrain sustainable earnings growth and reduce the effectiveness of retained funds.

Qianhai Health Holdings Ltd. News

0911 FAQ

What was Qianhai Health Holdings Ltd.’s price range in the past 12 months?
Qianhai Health Holdings Ltd. lowest stock price was HK$0.24 and its highest was HK$1.40 in the past 12 months.
What is Qianhai Health Holdings Ltd.’s market cap?
Qianhai Health Holdings Ltd.’s market cap is HK$54.22M.
When is Qianhai Health Holdings Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Qianhai Health Holdings Ltd.’s earnings last quarter?
Qianhai Health Holdings Ltd. released its earnings results on Aug 12, 2026. The company reported HK$0.017 earnings per share for the quarter.
Is Qianhai Health Holdings Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Qianhai Health Holdings Ltd. pay dividends?
Qianhai Health Holdings Ltd. pays a dividend of HK$0.1 which represents an annual dividend yield of ―. See more information on Qianhai Health Holdings Ltd. dividends here
What is Qianhai Health Holdings Ltd.’s EPS estimate?
Qianhai Health Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Qianhai Health Holdings Ltd. have?
Qianhai Health Holdings Ltd. has 169,445,000 shares outstanding.
What happened to Qianhai Health Holdings Ltd.’s price movement after its last earnings report?
Qianhai Health Holdings Ltd. reported an EPS of HK$0.017 in its last earnings report. Following the earnings report the stock price went up 1.818%.
Which hedge fund is a major shareholder of Qianhai Health Holdings Ltd.?
Currently, no hedge funds are holding shares in HK:0911
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology